Compare Immunovant Inc. Common Stock (IMVT) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Wendys Co — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Wendys Co trades at $6.21 (market cap $1.16B). The key difference: Immunovant Inc. Common Stock is far larger — about 5.7× Wendys Co's market cap, and Wendys Co pays a 4.59% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Wendys Co for 77 Days on average.
| IMVT | WEN | |
|---|---|---|
Market Cap | $6.62B | $1.16B |
Volume | 1,131,364 | 4,715,639 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $9.33 |
52-Week Low | $17.03 | $6.10 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $5.72B | $4.90B |
Dividend Yield | — | 4.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wendy's (WEN) trades at $6.22, up 0.97% today but remains under significant pressure with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 9.25 and P/S of 0.53, though fundamentals reveal declining profitability with net income margin dropping to 5.72% in 2025. Recent news highlights challenges including a major franchisee bankruptcy filing and six consecutive quarters of same-store sales declines, creating headwinds for the burger chain.
Despite low valuations and consistent earnings beats, Wendy's faces substantial operational challenges including franchisee instability and competitive pressures. The consensus price target of $7.58 suggests 22% upside potential, but investor sentiment remains cautious given the deteriorating fundamentals and bearish technical signals. Recovery depends on successful execution under new CEO Bob Wright and reversing negative sales trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
